Omass Therapeutics Australia Proprietary Ltd
Clinical trials sponsored by Omass Therapeutics Australia Proprietary Ltd, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- A randomized, phase 1, double-blind, single and Multiple-Ascending dose and food effect study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of OMS1620 in healthy participants Results expected May 2027 (estimated)